Recently, Gilead Sciences revealed that they had uncovered a dangerous drug-counterfeiting operation that targeted their HIV medications. This scheme, allegedly orchestrated out of two pharmacies in New York City, involved tampering with and improperly reselling the medications before reaching the patients. According to court documents unsealed this month, Peter Khaim, a twice-convicted medical fraudster, was
0 Comments
Investors looking to hedge against recent market volatility may find buffer ETFs to be a valuable asset. Bruce Bond, the CEO of Innovator ETFs, points out the advantage of buffer exchange-traded funds in providing protection from the market’s downside. According to Bond, this strategy caters to individuals who want market exposure without fully risking their
0 Comments
Starbucks, a well-known coffee giant, has been facing operational challenges that have impacted its sales and customer satisfaction. The incoming CEO, Brian Niccol, is expected to address these issues and turn the company around. Investors and executives have identified various culprits for the chain’s recent struggles, including operational inefficiencies, a weakening consumer base, boycotts, and
0 Comments